Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 1,287 | 2,270 | 2,754 | 2,827 | 13,935 |
| Operating Income | -1,287 | -2,270 | -2,754 | -2,827 | -13,935 |
| Interest Expense | 138 | 132 | 0 | 0 | 0 |
| Pre-tax Income | -1,425 | -2,401 | -2,754 | -2,827 | -13,935 |
| Income Tax | -3 | N/A | 10 | N/A | -597 |
| Net Income Continuous | -1,422 | -2,401 | -2,764 | -2,827 | -13,338 |
| Net Income | $-1,422 | $-2,401 | $-2,764 | $-2,827 | $-13,339 |
| EPS Basic Total Ops | 1.79 | -2.43 | -3.31 | -4.53 | 770.48 |
| EPS Basic Continuous Ops | 1.79 | -2.43 | -3.31 | -4.53 | 697.53 |
| EPS Diluted Total Ops | 1.79 | -2.43 | -3.31 | -4.53 | 770.48 |
| EPS Diluted Continuous Ops | 1.79 | -2.43 | -3.31 | -4.53 | 697.53 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.43 | -3.31 | N/A | N/A |
| EBITDA(a) | $-1,287 | $-2,268 | $-2,751 | $-2,824 | $-13,932 |